Genomic characterization and risk stratification of esophageal squamous dysplasia
Qingjie Min,Min Zhang,Dongmei Lin,Weimin Zhang,Xianfeng Li,Lianmei Zhao,Huajing Teng,Tao He,Wei Sun,Jiawen Fan,Xiying Yu,Jie Chen,Jinting Li,Xiaohan Gao,Bin Dong,Rui Liu,Xuefeng Liu,Yongmei Song,Yongping Cui,Shih-Hsin Lu,Ruiqiang Li,Mingzhou Guo,Yan Wang,Qimin Zhan
DOI: https://doi.org/10.1515/mr-2024-0008
2024-05-15
Abstract:Objectives: The majority of esophageal squamous dysplasia (ESD) patients progress slowly, while a subset of patients can undergo recurrence rapidly or progress to invasive cancer even after proper treatment. However, the molecular mechanisms underlying these clinical observations are still largely unknown. Methods: By sequencing the genomic data of 160 clinical samples from 49 tumor-free ESD patients and 88 esophageal squamous cell carcinoma (ESCC) patients, we demonstrated lower somatic mutation and copy number alteration (CNA) burden in ESD compared with ESCC. Results: Cross-species screening and functional assays identified ACSM5 as a novel driver gene for ESD progression. Furthermore, we revealed that miR-4292 promoted ESD progression and could serve as a non-invasive diagnostic marker for ESD. Conclusions: These findings largely expanded our understanding of ESD genetics and tumorigenesis, which possessed promising significance for improving early diagnosis, reducing overtreatment, and identifying high-risk ESD patients.